GSK-444563/006



To assess the efficacy, immuno & safety of 2 doses of GSK HRV vaccine at different virus concentrations in healthy infants aged 2 months & previously uninfected with HRV, concurrently given with DTPw-HBV, Hib.
Rotavirus Vaccine
444563/006
NCT00385320
Infections, Rotavirus
Phase 2
 
An annotated case report form is not available for this study. A blank case report form will be provided.
June 2015